noom glp 1 companion GLP-1 Noom Launches Free Version of

Note: Anti-Obesity GLP-1s Wegovy and Zepbound, Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA MAAS Patient Behavior Library Tool

Grateful if you can share this

Clinical trials are gold standard but they're also controlled, time-limited, and built around statistical averages

Bloating is a common digestive side effect reported by people starting semaglutide therapy

1 (2025 ): 400- Glycated hemoglobin (HbA1c) remains the gold standard for assessing long-term glycemic control, reflecting the average plasma glucose over the preceding 812 weeks

A new study provides the first clinical evidence that popular semaglutide drugs, like Ozempic or Wegovy, could slow down processes associated with biological aging.